Brief: Knight Therapeutics Inc: Entered In Definitive Asset Purchase Agreement With Endo & Paladin Pharma To Acquire Paladin Business
11/03/2025 10:48
March 11 (Reuters) - Paladin Ltd 0495.HK: KNIGHT THERAPEUTICS INC: WILL PAY AN UPFRONT PAYMENT OF $120 MILLION IN CASH, INCLUDING INVENTORY WITH A VALUE OF $20 MILLION KNIGHT THERAPEUTICS INC: ENTERED IN DEFINITIVE ASSET PURCHASE AGREEMENT WITH ENDO & PALADIN PHARMA TO ACQUIRE PALADIN BUSINESS KNIGHT THERAPEUTICS INC: MAY PAY FUTURE CONTINGENT PAYMENTS OF UP TO $15 MILLION UPON ACHIEVING CERTAIN SALES MILESTONES Source text: ID:nGNX7nXztv Further company coverage: 0495.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Paladin
See all newsBrief: Paladin Ltd Says FY Loss HK$145.3 Million
Brief: Knight Therapeutics Inc: Entered In Definitive Asset Purchase Agreement With Endo & Paladin Pharma To Acquire Paladin Business
Advisory: Alert on executive appointment wrongly tagged to Paladin Ltd withdrawn
Brief: Paladin Says Listing Division Of Stock Exchange Stated It Will Suspend Trading In Co's Shares
Brief: Paladin Sees Loss Of HK$130 Mln For Year